Main Session
Sep
29
SS 29 - Lung 3: NSCLC Early Stage and SBRT
272 - A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer
Presenter(s)
Mark Farrugia, MD, PhD - Roswell Park Cancer Institute, Buffalo, NY